These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37003132)
1. Hypoxia-induced UBE2K promotes the malignant progression of HCC. Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132 [TBL] [Abstract][Full Text] [Related]
2. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc. Lei X; Hu X; Lu Q; Yao Y; Sun W; Ma Q; Huang D; Xu Q Biochem Biophys Res Commun; 2023 Jan; 638():210-218. PubMed ID: 36481361 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma. Zhao F; Yu W; Hu J; Xia Y; Li Y; Liu S; Liu A; Wang C; Zhang H; Zhang L; Shi J Eur J Pharmacol; 2024 Jul; 974():176601. PubMed ID: 38677534 [TBL] [Abstract][Full Text] [Related]
4. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells. Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis. Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886 [TBL] [Abstract][Full Text] [Related]
6. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163 [TBL] [Abstract][Full Text] [Related]
7. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation. Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013 [TBL] [Abstract][Full Text] [Related]
8. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
10. The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma. Wang P; Tong K; Li Y; Li X; Zhang Y; Gu J; Lei P; Yan S; Hu P Cell Signal; 2024 Feb; 114():111007. PubMed ID: 38081444 [TBL] [Abstract][Full Text] [Related]
11. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression. Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595 [TBL] [Abstract][Full Text] [Related]
12. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo. Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447 [TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis. Fei M; Guan J; Xue T; Qin L; Tang C; Cui G; Wang Y; Gong H; Feng W Cell Mol Biol Lett; 2018; 23():46. PubMed ID: 30258464 [TBL] [Abstract][Full Text] [Related]
15. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells. Xu LF; Ni JY; Sun HL; Chen YT; Wu YD World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163 [TBL] [Abstract][Full Text] [Related]
16. SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1α-dependent mitochondrial damage. Luo D; Wang Y; Zhang M; Li H; Zhao D; Li H; Chen X; Jin C; Han B Cell Death Dis; 2022 Nov; 13(11):918. PubMed ID: 36319626 [TBL] [Abstract][Full Text] [Related]
17. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380 [TBL] [Abstract][Full Text] [Related]
18. [Effects of hypoxia inducible factor-1α on P311 and its influence on the migration of murine epidermal stem cells]. Xu ZD; Li HS; Wang S; He WF; Wu J; Luo GX Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):287-294. PubMed ID: 28651420 [No Abstract] [Full Text] [Related]
19. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma. Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971 [TBL] [Abstract][Full Text] [Related]
20. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway. Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]